Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 8/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5562193 | 0.90 | SLC6A9 (0.56) | SLC6A9MAOA | |
| SCHEMBL5556904 | 0.74 | SLC6A9 (0.55) | SLC6A9 | |
| SCHEMBL1138347 | 0.71 | SLC6A9 (0.58) | SLC6A9 | |
| SCHEMBL5556903 | 0.71 | SLC6A9 (0.58) | SLC6A9 | |
| SCHEMBL5561878 | 0.71 | SLC6A9 (0.58) | SLC6A9 | |
| SCHEMBL4339185 | 0.71 | SLC6A9 (0.42) | SLC6A9 | |
| SCHEMBL1138335 | 0.71 | SLC6A9 (0.56) | SLC6A9 | |
| Hydrochloric Acid SCHEMBL5562493 | 0.70 | SLC6A9 (0.57) | SLC6A9 | |
| SCHEMBL5563352 | 0.69 | SLC6A9 (0.54) | SLC6A9 | |
| SCHEMBL2875597 | 0.69 | HTR1A (0.47) | SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1716147-A1 | DIAZA-SPIROPIPERIDINE DERIVATIVES AS INHIBITORS OF GLYCINE TRANSPORTER 1 AND GLYCINE TRANSPORTER 2 | F.HOFFMANN-LA ROCHE AG (CH) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005068462-A1 | DIAZA-SPIROPIPERIDINE DERIVATIVES AS INHIBITORS OF TRANSPORTER 1 AND GLYCINE TRANSPORTER 2 | F. HOFFMANN-LA ROCHE AG (CH) | 2005-07-28 | — | — | WO | disclosed |